Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 64.05 -0.14% -0.09
MRTX closed up 2.67 percent on Thursday, January 17, 2019, on 3.05 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MRTX trend table...

Date Alert Name Type % Chg
Jan 17 Pocket Pivot Bullish Swing Setup -0.14%
Jan 17 Volume Surge Other -0.14%
Jan 17 Calm After Storm Range Contraction -0.14%
Jan 17 NR7 Range Contraction -0.14%
Jan 17 Inside Day Range Contraction -0.14%
Jan 17 Wide Bands Range Expansion -0.14%
Jan 17 Overbought Stochastic Strength -0.14%
Jan 16 Bearish Engulfing Bearish 2.53%
Jan 16 Slingshot Bullish Bullish Swing Setup 2.53%
Jan 16 New 52 Week High Strength 2.53%

Older signals for MRTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Is MRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.13
52 Week Low 24.65
Average Volume 632,174
200-Day Moving Average 45.2082
50-Day Moving Average 43.2322
20-Day Moving Average 48.6685
10-Day Moving Average 57.46
Average True Range 3.8416
ADX 38.99
+DI 38.9915
-DI 8.2467
Chandelier Exit (Long, 3 ATRs ) 55.6052
Chandelier Exit (Short, 3 ATRs ) 45.9148
Upper Bollinger Band 69.2626
Lower Bollinger Band 28.0744
Percent B (%b) 0.88
BandWidth 84.6301
MACD Line 6.3827
MACD Signal Line 4.4542
MACD Histogram 1.9285
Fundamentals Value
Market Cap 1.6 Billion
Num Shares 25 Million
EPS -3.38
Price-to-Earnings (P/E) Ratio -18.98
Price-to-Sales 0.00
Price-to-Book 3.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 67.82
Resistance 3 (R3) 67.83 66.61 67.20
Resistance 2 (R2) 66.61 65.68 66.61 67.00
Resistance 1 (R1) 65.38 65.10 66.00 65.37 66.79
Pivot Point 64.16 64.16 64.47 64.16 64.16
Support 1 (S1) 62.93 63.23 63.55 62.92 61.49
Support 2 (S2) 61.71 62.65 61.71 61.28
Support 3 (S3) 60.48 61.71 61.08
Support 4 (S4) 60.47